Ali Al Saegh

Ali Al Saegh

Auto-generated profile, based on publicly available information

Ali Al Saegh


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
APAutumn Paluck
Autumn Paluck
JOJaspreet Kaur Osan
Jaspreet Kaur Osan
LHLauren Hollingsworth
Lauren Hollingsworth
STSattya Narayan Talukdar
Sattya Narayan Talukdar
ASAli Al Saegh
Ali Al Saegh
Masfique MehediMasfique Mehedi
Masfique Mehedi
Respiratory syncytial virus (RSV) is the leading viral agent causing bronchiolitis and pneumonia in children under five years old worldwide. The RSV infection cycle starts with macropinocytosis-based entry into the host airway epithelial cell membrane, followed by virus transcription, replication, assembly, budding, and spread. It is not surprising that the host actin cytoskeleton contributes to different stages of the RSV replication cycle. RSV modulates actin-related protein 2/3 (ARP2/3) complex-driven actin polymerization for a robust filopodia induction on the infected lung epithelial A549 cells, which contributes to the virus’s budding, and cell-to-cell spread. Thus, a comprehensive understanding of RSV-induced cytoskeletal modulation and its role in lung pathobiology may identify novel intervention strategies. This review will focus on the role of the ARP2/3 complex in RSV’s pathogenesis and possible therapeutic targets to the ARP2/3 complex for RSV.